Mobile Application to Collect PRO Data in NET Patients
ConditionNeuroendocrine Neoplasms (Tumours)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKing's College Hospital NHS Trust
About this trial
Observational trial to assess the feasibility of monitoring patient reporting symptoms via mobile devices
Eligibility criteria
Qualifiers
Histologically confirmed diagnosis of a NET
Planned treatment for NET
Able to give informed consent
Able to understand the language of the questionnaires
Disqualifiers
Concurrent malignancies for which they are undergoing treatment
No smartphone / device
Any physical, psychological or comprehension problems that prevents completion of questionnaires.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 1 trial groupSponsors and collaborators
King's College Hospital NHS Trust
Lead sponsor
Ampersand Health Ltd
Collaborator
Neuroendocrine Cancer UK
Collaborator
Source ClinicalTrials.gov